


Ask a doctor about a prescription for GRANPIDAM 20 mg FILM-COATED TABLETS
Package Leaflet: Information for the Patient
Granpidam 20 mg film-coated tablets EFG
sildenafil
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Keep this leaflet, you may need to read it again.
Contents of the pack
Granpidam contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 inhibitors (PDE5).
Granpidam reduces blood pressure in the lungs by widening the blood vessels in the lungs. Granpidam is used to treat high blood pressure in the blood vessels of the lungs (pulmonary arterial hypertension) in adults and children and adolescents from 1 to 17 years.
Do not take Granpidam
Warnings and precautions
Consult your doctor or pharmacist before starting Granpidam if
When PDE5 inhibitors, including sildenafil, are used to treat erectile dysfunction (ED), the following visual adverse effects have been reported with an unknown frequency: decrease or loss of vision, sudden, temporary, or permanent, in one or both eyes. If you experience a reduction or loss of vision, stop taking Granpidam and inform your doctor immediately(see also section 4).
Prolonged and sometimes painful erections have been observed in men taking sildenafil. If you have an erection that lasts for more than 4 hours, stop taking Granpidam and consult your doctor immediately(see also section 4).
Special precautions in patients with kidney or liver problems
You should inform your doctor if you have kidney or liver problems, as a dose adjustment may be necessary.
Children
Granpidam should not be administered to children under 1 year of age.
Other medicines and Granpidam
Inform your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
Taking Granpidam with food and drinks
Do not take grapefruit juice when being treated with Granpidam.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Granpidam should not be used during pregnancy unless absolutely necessary. Granpidam should not be administered to women of childbearing age unless adequate contraceptive methods are used.
Granpidam passes into breast milk at very low levels and is not expected to harm your baby.
Driving and using machines
Granpidam may cause dizziness and affect vision. You should know how you react to this medicine before driving vehicles or using machines.
Granpidam contains lactose
Before taking this medicine, consult your doctor if you have been told you have an intolerance to some sugars.
Granpidam contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet. This means that it is essentially “sodium-free”.
Always take this medicine exactly as your doctor has told you. If you are not sure, consult your doctor or pharmacist.
For adults, the recommended dose is 20 mg three times a day (taken at intervals of 6 to 8 hours) taken with or without food.
Use in children and adolescents
For children and adolescents from 1 to 17 years, the recommended dose is 10 mg three times a day for children and adolescents ≤ 20 kg or 20 mg three times a day in children and adolescents > 20 kg, administered with or without food. In children, doses higher than those recommended should not be used.
This medicine should only be used for cases where 20 mg three times a day should be administered. For administration in patients ≤ 20 kg and in other younger patients who cannot swallow tablets, other pharmaceutical forms more suitable for their needs may be used.
If you take more Granpidam than you should
Do not take more medicine than your doctor has prescribed.
If you have taken more medicine than you should, consult your doctor immediately. Taking more Granpidam than you should can increase the risk of known side effects.
If you forget to take Granpidam
If you have forgotten to take Granpidam, take the dose as soon as you remember and continue taking your medicine at the usual times. Do not take a double dose to make up for forgotten doses.
If you stop taking Granpidam
Sudden interruption of treatment with Granpidam may lead to worsening of your symptoms. Do not stop taking Granpidam unless your doctor tells you to. Your doctor will tell you how to reduce the dose over a few days before stopping it completely.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you experience any of the following side effects, stop taking Granpidam and inform your doctor immediately (see also section 2):
Adults
The very common side effects (may affect more than 1 in 10 people) were headache or facial flushing, indigestion, diarrhea, and pain in arms and legs.
The common side effects (may affect up to 1 in 10 people) are: skin infection, flu-like symptoms, nasal congestion, reduction in red blood cell count (anemia), fluid retention, difficulty sleeping, anxiety, migraine, tremor, tingling sensation, burning sensation, reduced sense of touch, bleeding in the back of the eye, changes in vision, blurred vision, and sensitivity to light, effects on color perception, eye irritation, red eyes, dizziness, bronchitis, nosebleeds, runny nose, cough, stuffy nose, stomach inflammation, gastroenteritis, heartburn, hemorrhoids, abdominal distension, dry mouth, hair loss, skin flushing, night sweats, muscle pain, back pain, and increased body temperature.
The uncommon side effects (may affect up to 1 in 100 people) included: reduced visual acuity, double vision, abnormal sensation in the eye, penile bleeding, presence of blood in semen and/or urine, and gynecomastia in men.
Also, skin rash, sudden loss of hearing, and decreased blood pressure have been reported with an unknown frequency (the frequency cannot be estimated from the available data).
Children and adolescents
The following serious side effects have been reported frequently (may affect up to 1 in 10 people): pneumonia, right heart failure, cardiac arrest, high blood pressure in the lungs, chest pain, dizziness, respiratory infections, bronchitis, viral gastroenteritis, urinary tract infections, and tooth abscesses.
The following serious side effects were considered related to treatment and reported infrequently (may affect up to 1 in 100 people): allergic reaction (such as skin rash, facial swelling, lip and tongue swelling, sneezing, difficulty breathing or swallowing), seizures, irregular heartbeat, hearing disorders, shortness of breath, gastrointestinal inflammation, and sneezing due to airway disorders.
The very common side effects (may affect more than 1 in 10 people) were headache, vomiting, throat infection, fever, diarrhea, flu, and nosebleeds.
The common side effects (may affect up to 1 in 10 people) were nausea, increased erections, pneumonia, and runny nose.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of the month shown.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Granpidam
Appearance of Granpidam and contents of the pack
White to off-white, round, approximately 6.6 mm in diameter, biconvex, film-coated tablets, marked with "20" on one side and plain on the other.
Granpidam 20 mg film-coated tablets are available in PVC/Alu blister packs containing 90 and 300 tablets.
Granpidam 20 mg film-coated tablets are also available in unit-dose blister packs of PVC/Alu containing 15x1, 90x1, and 300x1 tablets.
Not all pack sizes may be marketed.
Marketing authorisation holder and manufacturer
Marketing authorisation holder:
Accord Healthcare S.L.U.
World Trade Center, Moll de Barcelona, s/n,
Edifici Est 6ª planta,
08039 Barcelona,
Spain
Manufacturer:
Wessling Hungary Kft
Fòti ùt 56., Budapest 1047,
Hungary
or
Laboratori Fundació DAU
C/ C, 12-14 Pol. Ind. Zona Franca, 08040 Barcelona,
Spain
or
Accord Healthcare Polska Sp.z o.o.,
ul. Lutomierska 50,95-200 Pabianice,
Poland
Date of last revision of this leaflet:
Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for GRANPIDAM 20 mg FILM-COATED TABLETS – subject to medical assessment and local rules.